Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study confirms benefits of hemispherectomy surgery

14.10.2003


A new study by Johns Hopkins Children’s Center scientists confirms the lasting benefits of hemispherectomy, a dramatic operation in which half the brain is removed to relieve frequent severe seizures that medications cannot control.



Results of the study, published in the Oct. 14 issue of Neurology, show that 86 percent of the 111 children who underwent hemispherectomy at the Children’s Center between 1975 and 2001 are either seizure-free or have non-disabling seizures that do not require medication.

These results are slightly improved over a 1997 study of 58 Hopkins hemispherectomy patients which found that 78 percent of children were either seizure-free or had mild seizures.


The findings should help parents who are still contemplating whether their child would benefit from the surgery, said the study’s lead author, Eric Kossoff, M.D., a pediatric epileptologist at the Children’s Center.

"It’s clear now that the quality of life of children with chronic, severe seizures greatly improves following hemispherectomy," he said. "In almost all cases, the children no longer depend on multiple medications, and post-operatively, most of the children are walking and running and living normal lives."

All hemispherectomy patients have partial paralysis on the side of the body opposite the removed portion. However, "except for a few with major postoperative complications, such as meningitis and edema, all the children we followed up with are up and about and most have adapted to their handicapped side so well that they play the piano, golf, ping-pong and can dance," Kossoff added.

In the latest study, Hopkins researchers reviewed the charts and contacted many of the families of the 58 children who participated in the 1997 study, as well as 53 other children who subsequently had a Hopkins hemispherectomy. They found 65 percent are seizure-free, 21 percent have occasional, non-handicapping seizures, and 14 percent have troublesome seizures. Eighty percent of patients no longer use drugs or are taking only one anti-convulsant medication.

The researchers say patients with Rasmussen’s syndrome, a rare nervous system disorder characterized by chronic inflammation of the brain, and those with congenital vascular injuries benefit the most from hemispherectomy. Sixty-five percent of Rasmussen’s patients and 81 percent of patients with vascular injuries are now seizure-free.

Although children with disorders of brain development (dysplasias) have just a 50/50 chance of being seizure-free following the surgery, even those with persistent seizures after surgery experience a reduction in the number of seizures, Kossoff said.

The surgery, which leaves intact the deep structures of the brain (the thalamus, brain stem and basal ganglia), is performed at Hopkins on children with Rasmussen’s syndrome, a variety of developmental abnormalities on one side of the brain, and on those who have had disabling strokes. Because children’s brains are "plastic," if surgeons remove the affected portion of the brain, the remaining portion overtakes most of the functions of the missing side.

Hemispherectomy was first attempted in the 1920s by Hopkins neurosurgeon Walter E. Dandy, M.D. It was reintroduced at Hopkins in 1968 and was refined in the 1980s by Benjamin S. Carson, M.D., director of pediatric neurosurgery at the Children’s Center and a co-author of the current study.

Additional co-authors are Eileen P.G. Vining, Diana J. Pillas, Paula L. Pyzik, Anthony M. Avellino, and John M. Freeman, all of the department of pediatric neurology and neurosurgery at the Johns Hopkins Children’s Center. (Dr. Avellino is now on the faculty at the University of Washington School of Medicine.)


The study was supported in part by The Roxanne Fund.


Johns Hopkins Medicine
Office of Communications and Public Affairs
Media Contact: Jessica Collins (410) 516-4570
Email: jcolli31@jhmi.edu

Jessica Collins | EurekAlert!
Further information:
http://www.hopkinsmedicine.org/

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

New bioimaging technique is fast and economical

21.08.2017 | Medical Engineering

Silk could improve sensitivity, flexibility of wearable body sensors

21.08.2017 | Materials Sciences

On the way to developing a new active ingredient against chronic infections

21.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>